Sr. Vice President, Marketing and Strategy @ Akebia/Keryx (July 2016 - February 2021)
Senior Vice President and General Manager, Head of Global Renal Division @ (December 2012 - September 2014)
Senior Vice President Marketing @ (May 2002 - December 2012)
Vice President of Marketing @ (May 2001 - May 2003)
Senior Director Marketing @ (January 1996 - January 2002)
Product Manager @ (January 1989 - January 1996)
Process Development Chemist @ Hybritech, An Eli Lilly Company (January 1986 - August 1987)
Doug Jermasek Education
Brigham Young University Marriott School of Business
MBA (Business Administration and General Management, Marketing, Corporate Strategy)
1987-1989
Armstrong Senior High School 1974-1978
Doug Jermasek Skills
Leadership
Clinical Trials
Integrity
Cardiology
Neurology
Infectious Diseases
Biotechnology
Healthcare
Life Sciences
International Marketing
Strategic Planning
Global Marketing
Medical Devices
Strategy
Yoga Teacher Training
Analytical Chemistry
Lifesciences
Microsoft Office
Sales Effectiveness
Oncology
Marketing
Cross Functional Team Leadership
Clinical Development
Product Management
Managed Care
Business Strategy
Management
Product Launch
Pharmaceutical Industry
Pharmaceutical Sales
Market Access
Marketing Strategy
Commercialization
Biopharmaceuticals
Doug Jermasek Summary
Doug Jermasek, based in California, United States, is currently a Executive Vice President, Corporate Strategy at Unicycive Therapeutics Inc. Doug Jermasek brings experience from previous roles at Akebia/Keryx, Sanofi, Genzyme, a Sanofi company and Prometheus Laboratories Inc., A Nestlé Health Science Company. Doug Jermasek holds a 1987 - 1989 MBA in Business Administration and General Management, Marketing, Corporate Strategy @ Brigham Young University Marriott School of Business. With a robust skill set that includes Leadership, Clinical Trials, Integrity, Cardiology, Neurology and more. Doug Jermasek has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Doug Jermasek?
Find contact details for 700 million professionals.